Neuroprotective and Nootropic Potential of Trapa natans: Current Evidence, Proposed Mechanisms and Research Gaps
Cognitive impairment is a major neurological concern associated with aging and neurodegenerative disorders, and oxidative stress and impaired cholinergic neurotransmission are among the mechanisms implicated in its progression. Trapa natans L. (water chestnut) has traditionally been used as a food and medicinal plant and has attracted pharmacological interest because of its phenolic, flavonoid and other bioactive constituents. However, the evidence supporting its cognitive-enhancing and neuroprotective effects remains limited and heterogeneous. This review summarizes the current experimental evidence on the nootropic and neuroprotective potential of T. natans, with particular emphasis on behavioral outcomes, oxidative stress-related mechanisms, and the scopolamine-induced model of cognitive impairment. Available preclinical evidence indicates that hydroalcoholic extracts of the dried fruits of T. natans var. bispinosa can improve performance in elevated plus-maze and passive-avoidance paradigms and attenuate scopolamine-induced memory impairment in mice. Importantly, the available cognitive study did not demonstrate an alteration in brain acetylcholinesterase activity, indicating that direct acetylcholinesterase inhibition should not currently be considered an established mechanism. Additional experimental evidence suggests antioxidant activity of T. natans extracts, including reduction of lipid peroxidation and modulation of antioxidant enzymes in an experimental aging model, while in vitro studies have demonstrated free-radical-scavenging activity of fruit-rind extracts. Mechanisms involving cholinergic modulation, Nrf2 signaling, neuroinflammation, microglial regulation, and synaptic protection may represent potential pathways but require direct validation in T. natans-specific neurological models. Overall, current evidence provides a preliminary preclinical basis for the cognitive and antioxidant potential of T. natans; however, species/taxonomic nomenclature, plant part, extract composition, dose, experimental model and mechanistic endpoints vary substantially across studies. Further standardized pharmacological, pharmacokinetic, toxicological and clinical investigations are required to establish its therapeutic relevance.
Authors
- Jitendra Banweer (ORCID: https://orcid.org/0009-0001-3978-1807)
- Sarika Shrivastava (ORCID: https://orcid.org/0000-0002-2732-7594)
- Abhishek Kushwaha
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24415052
- Primary Topic
- Medicinal Plants and Neuroprotection
- Type
- article
- Field-Weighted Citation Impact
- 0.00